Lupus Research Alliance Welcomes Steve Burke, Selena Gomez, Seth Meyers and Kelli O’Hara to Breaking through Lupus Gala Raises Over $3.2 Million for Lupus Research November 21, 2017 – New York, NY – The Lupus Research Alliance celebrated the 2017 Breaking through Lupus Gala to shed a spotlight on breakthroughs from the previous years, and […] READ MORE
Two Outstanding Scientists Recognized for Transformative Lupus Research Projects Nov. 09, 2017. The Lupus Research Alliance is proud to announce the 2017 recipients of the Dr. William E. Paul Distinguished Innovator Awards in Lupus and Autoimmunity. Michael Carroll, PhD, Children’s Hospital Boston, is studying why and how lupus attacks the brain and central nervous system […] READ MORE
Lupus Research Alliance welcomes compelling new data, presented at the American College of Rheumatology (ACR) annual meeting that demonstrated significant benefit for lupus patients treated with Stelara® (ustekinumab), a prescription medicine from the Janssen Pharmaceutical Companies. Stelara® is not approved for the treatment of lupus, but is approved by the FDA for certain autoimmune diseases. Through its drug repurposing program, the Lupus Research Alliance first identified Stelara® as a potential treatment for lupus and encouraged Janssen to pursue testing for this use. READ MORE
NEW YORK, NY. October 31, 2017 — The Lupus Research Alliance today announced the first clinical trials to be conducted through its Lupus Clinical Investigators Network (LuCIN) aimed at discovering new treatments for the millions of people around the globe living with lupus. Recognizing the limited treatments for lupus, LuCIN was organized, managed and is […] READ MORE
The Lupus Research Alliance congratulates GlaxoSmithKline (GSK) on the approval of belimumab (Benlysta®) by the U.S. Food and Drug Administration as a self-injectable (subcutaneous) formulation for people with systemic lupus erythematosus being treated with standard therapy. Belimumab is currently approved as a one-hour intravenous infusion given once every four weeks by a healthcare professional in […] READ MORE
Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus. The study is published in the July 17 issue of the journal Nature Communications and was led by researchers at Wake Forest Baptist Medical Center, Oklahoma Medical Research Foundation, King’s College of London and Genentech Inc. Autoimmune diseases […] READ MORE
App developed by Lupus Research Alliance, Pfizer Inc. and Tata to be tested through non-interventional clinical trial called VALUE NEW YORK, N.Y. — The Lupus Research Alliance, the world’s largest private funder of lupus research, and Pfizer Inc., the global biopharmaceutical company, announced the start of a non-interventional clinical study that will test a custom smartphone […] READ MORE
May 2, 2017. NEW YORK, NY. A bipartisan spending bill for Fiscal 2017 that includes key provisions the Lupus Research Alliance and lupus advocates across the country have fought for is well on its way to becoming law this week. H.R. 244 has been introduced in the House of Representatives for a vote later this week […] READ MORE
Unites Global Community to Free the World of Lupus through the Power of Science NEW YORK, NY. May 1. – The Lupus Research Alliance today kicks off its Breaking through for YOU campaign to mark its inaugural Lupus Awareness Month. The newly merged organization’s first campaign draws the world’s attention to the urgent need to […] READ MORE
NEW YORK, NY – April 4, 2017. Nearly 300 prominent women and men from New York’s fashion, society, entertainment, publishing, philanthropic and lupus communities came together today to raise funds for lupus research. The 8th annual Lupus Handbag Luncheon & Silent Auction was the first hosted by the Lupus Research Alliance, formed by the recent merger […] READ MORE
Demonstrates the Power of Patient Advocacy Lupus patients will have a new medical research program at work for them in the future if Bill H.R. 1301 passed today by the House of Representatives becomes law. The House approved the Fiscal 2017 Defense Appropriations Conference Report which designates $5 million for new peer-reviewed lupus research under […] READ MORE
The Lupus Research Alliance proudly announces that the last major hurdle to the 21st Century Cures Act has been cleared as the U.S. Senate joined the House of Representatives in voting for its passage by an overwhelming majority vote of 94 to 5. Capping two years of consistent advocacy work, the bill is now cleared […] READ MORE
